We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+4.26%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.92B
AUM Growth
+$1.77B
Cap. Flow
+$1.61B
Cap. Flow %
27.24%
Top 10 Hldgs %
29.35%
Holding
6,215
New
374
Increased
3,547
Reduced
1,424
Closed
549

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$87.5M
2
AAPL icon
Apple
AAPL
+$68.6M
3
AMZN icon
Amazon
AMZN
+$62.8M
4
META icon
Meta Platforms (Facebook)
META
+$41.4M
5
AMD icon
Advanced Micro Devices
AMD
+$39.4M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$158M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$70.2M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$34.4M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$33.9M
5
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$22.9M

Sector Composition

Rank Sector Weight
1 Technology 29.49%
2 Consumer Discretionary 9.8%
3 Financials 9.15%
4 Healthcare 9.12%
5 Communication Services 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCLX icon
3551
Scilex Holding
SCLX
$47M
$27.6K ﹤0.01%
409
-278
-40% -$11.7K
FRGE
3552
DELISTED
Forge Global Holdings
FRGE
$27.5K ﹤0.01%
1,257
+888
+241% +$23.6K
TSBX
3553
DELISTED
Turnstone Biologics
TSBX
$27.5K ﹤0.01%
10,502
+7,093
+208% +$20.3K
ANGO icon
3554
AngioDynamics
ANGO
$646M
$27.4K ﹤0.01%
4,523
+1,176
+35% +$7.26K
GEVO icon
3555
Gevo
GEVO
$388M
$27.3K ﹤0.01%
49,077
+47,469
+2,952% +$31.8K
CHRS icon
3556
Coherus Oncology
CHRS
$185M
$27.3K ﹤0.01%
+15,773
New +$31.7K
MVST icon
3557
Microvast
MVST
$335M
$27.2K ﹤0.01%
59,684
+55,762
+1,422% +$25K
EGAN icon
3558
eGain
EGAN
$200M
$27.2K ﹤0.01%
4,307
-978
-19% -$6.07K
GILT icon
3559
Gilat Satellite Networks
GILT
$878M
$27.2K ﹤0.01%
+6,076
New +$32.3K
NGD
3560
DELISTED
New Gold Inc
NGD
$27.1K ﹤0.01%
13,922
-23,627
-63% -$44.9K
CMT icon
3561
Core Molding Technologies
CMT
$226M
$27.1K ﹤0.01%
1,698
+1,094
+181% +$20K
LAW icon
3562
CS Disco
LAW
$273M
$27.1K ﹤0.01%
4,541
+3,391
+295% +$23.4K
FBZ
3563
DELISTED
First Trust Brazil AlphaDEX Fund
FBZ
$27K ﹤0.01%
2,582
-340
-12% -$3.84K
LAZ icon
3564
Lazard
LAZ
$4.21B
$27K ﹤0.01%
706
-2,391
-77% -$93.4K
BCBP icon
3565
BCB Bancorp
BCBP
$161M
$26.9K ﹤0.01%
2,534
+2,092
+473% +$20.9K
HUN icon
3566
Huntsman Corp
HUN
$1.79B
$26.9K ﹤0.01%
1,182
+618
+110% +$15.1K
PRLD icon
3567
Prelude Therapeutics
PRLD
$441M
$26.9K ﹤0.01%
7,064
+3,717
+111% +$15.1K
TG icon
3568
Tredegar Corp
TG
$279M
$26.9K ﹤0.01%
5,613
+4,339
+341% +$25.3K
EDV icon
3569
Vanguard World Funds Extended Duration ETF
EDV
$3.47B
$26.9K ﹤0.01%
+366
New +$26.5K
ORGO icon
3570
Organogenesis Holdings
ORGO
$228M
$26.7K ﹤0.01%
9,551
+8,880
+1,323% +$23.8K
SEER icon
3571
Seer Inc
SEER
$118M
$26.7K ﹤0.01%
15,878
+14,222
+859% +$26.6K
GOCO
3572
DELISTED
GoHealth
GOCO
$26.7K ﹤0.01%
2,742
+1,916
+232% +$19K
TTSH
3573
DELISTED
Tile Shop Holdings
TTSH
$26.6K ﹤0.01%
3,845
+3,668
+2,072% +$24.6K
LQD icon
3574
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.7B
$26.6K ﹤0.01%
248
+129
+108% +$13.8K
PRME icon
3575
Prime Medicine
PRME
$579M
$26.5K ﹤0.01%
5,157
-1,906
-27% -$11.6K
141 142
143
144 145

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2024 Portfolio in Review

As of Q2 2024, Tower Research Capital (TRC) held 6,215 positions worth $5.92B, up 43% from $4.15B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $1.61B of net new capital in Q2 2024, opening 374 new positions and adding to 3,547 existing holdings. Its largest new stake was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $158M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2024 buy was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.
  • Tower Research Capital (TRC) added most to Microsoft in Q2 2024, an estimated $87.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $158M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q2 2024, selling an estimated $18.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $5.92B portfolio in Q2 2024.
  • Tower Research Capital (TRC) opened 374 new positions and closed 549 in Q2 2024.
  • Tower Research Capital (TRC)'s portfolio value rose 43% quarter-over-quarter to $5.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.